Introduction of novel semiquantitative evaluation of 99mTc-MIBI SPECT before and after treatment of glioma

Medicina (Lithuania)

Volumn 48, Issue 1, 2012, Pages 15-21

  Deltuva, Vytenis Pranas ^a   Jurkiene, Nemira ^a   Kulakiene, Ilona ^a   Bunevičius, Adomas ^a   Matukevičius, Algimantas ^a   Tamašauskas, Arimantas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Glioma; Grade; Single photon emission computed tomography

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; FEMALE; GLIOMA; HUMAN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SCINTISCANNING; VALIDATION STUDY; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MIDDLE AGED; NEOPLASM GRADING; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; YOUNG ADULT;

EID: 84861465840     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina48010003     Document Type: Article

References (31)

1. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-23.
2. Rigau V, Zouaoui S, Mathieu-Daudé H, Darlix A, Maran A, Trétarre B, et al. French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol 2011;21(6):633-44.
3. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol 2003;30:10-4.
4. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005;64:479-89.
5. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010;60:166-93.
6. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
7. Bunevicius A, Deltuva VP, Deltuviene D, Tamasauskas A, Bunevicius R. Brain lesions manifesting as psychiatric disorders: eight cases. CNS Spectr 2008;13:950-8.
8. Filippi L, Schillaci O, Santoni R, Manni C, Danieli R, Simonetti G. Imaging primary brain tumors by single-photon emission computerized tomography (SPECT) with technetium-99m sestamibi (MIBI) and tetrofosmin. Curr Med Imag Rev 2005;1:61-6.
9. Henkin RE, Bova D, Dillehay GL. Nuclear medicine. 2nd ed. Philadelphia: Mosby Elsevier; 2006.
10. Sartor K. MR imaging of the brain: tumors. Eur Radiol 1999;9:1047-54.
11. Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R, et al. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol 2009;11:176-82.
12. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-6.
13. Baillet G, Albuquerque L, Chen Q, Poisson M, Delattre JY. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 1994;21:1061-6.
14. Gómez-Río M, Rodríguez-Fernández A, Ramos-Font C, López-Ramírez E, Llamas-Elvira JM. Diagnostic accuracy of (201)Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence. Eur J Nucl Med Mol Imaging 2008;35:966-75.
15. Le Jeune FP, Dubois F, Blond S, Steinling M. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J Neurooncol 2006;77:177-83.
16. Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, et al. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 1998;89:60-8.
17. Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia A, Voulgaris S, et al. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme. J Nucl Med 2010;51:1923-6.
18. Prigent-Le Jeune F, Dubois F, Perez S, Blond S, Steinling M. Technetium-99m sestamibi brain SPECT in the followup of glioma for evaluation of response to chemotherapy: first results. Eur J Nucl Med Mol Imaging 2004;31:714-9.
19. Kallén K, Burtscher IM, Holtås S, Ryding E, Rosén I. 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas. J Neurooncol 2000;46:173-85.
20. Vos MJ, Tony BN, Hoekstra OS, Postma TJ, Heimans JJ, Hooft L. Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma. Nucl Med Commun 2007;28: 431-9.
21. Ak I, Gulbas Z, Altinel F, Vardareli E. 99mTc-MIBI uptake and its relation to the proliferative potential of brain tumors. Clin Nucl Med 2003;28:29-33.
22. Baillet G, Albuquerque L, Chen Q, Poisson M, Delattre JY. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 1994;21:1061-6.
23. Kumabe T, Shimizu H, Sonoda Y, Shirane R. Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: three technical case reports. Neurosurgery 1999;45(1):183-7.
24. Datta NR, Pasricha R, Gambhir S, Phadke RV, Prasad SN. Postoperative residual tumour imaged by contrast-enhanced computed tomography and 201Tl single photon emission tomography: can they predict progression-free survival in high-grade gliomas? Clin Oncol (R Coll Radiol) 2004;16: 494-500.
25. Weber WA, Dick S, Reidl G, Dzewas B, Busch R, Feldmann HJ. Correlation between postoperative 3-(123I)iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 2001;42:1144-50.
26. Beauchesne P, Pedeux R, Boniol M, Soler C. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med 2004;45:409-13.
27. Cheng X, Li Y, Xu Z, Li D, Wang J. A meta-analysis of 99mTc-MIBI SPECT for detection of recurrent glioma after radiation therapy. J Clin Neurosci 2011;18:307-12.
28. Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, et al. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Clin Neurol Neurosurg 2010;112:758-65.
29. Xiangsong Z, Weian C. Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET. J Neurooncol 2007;82:305-11.
30. Santra A, Kumar R, Sharma P, Bal C, Julka PK, Malhotra A. Detection of recurrence in glioma: a comparative prospective study between 99mTc-GHA SPECT and 18F-FDG PET/CT. Clin Nucl Med 2011;36:650-5.
31. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 2008;49: 694-9.